Peter G Smith

This inventor holds 16 USPTO granted patents and 29 published patent applications, plus 3 CIPO patents and 8 EPO patents. Top assignees: Eisai R&d Management Co., Ltd., Millennium Pharmaceuticals Limited, The General Hospital Corporation. Active years: 2015-2024.

USPTO Granted Patents = 16 (Patent Applications = 29)

% Patents Active = 93.8

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 14(Granted Patents)

Company Filing History:

13 out of 530

Eisai R&d Management Co., Ltd.

patents

3 out of 854

Millennium Pharmaceuticals Limited

patents

1 out of 3,067

The General Hospital Corporation

patents

where one patent can have more than one assignee

Years Active: 2015-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12172986 - Splicing modulator antibody-drug conjugates and methods of use (2024-12-24),

2. 11945807 - Splicing modulator antibody-drug conjugates and methods of use (2024-04-02),

3. 11833119 - Combination therapies for the treatment of hepatocellular carcinoma (2023-12-05),

4. 11761045 - Splice variants associated with neomorphic SF3B1 mutants (2023-09-19),

5. 11524009 - Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors and methods of use (2022-12-13),

6. 11357769 - Drug combinations for reducing cell viability and/or cell proliferation (2022-06-14),

7. 11352348 - Splicing modulator antibody-drug conjugates and methods of use (2022-06-07),

8. 11083722 - Combination therapies for the treatment of breast cancer (2021-08-10),

9. 10953013 - Biomarkers of response to NAE inhibitors (2021-03-23),

10. 10889866 - Splice variants associated with neomorphic SF3B1 mutants (2021-01-12),

11. 10851065 - Tetrasubstituted alkene compounds and their use (2020-12-01),

12. 10745387 - Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(piridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate and methods of use thereof (2020-08-18),

13. 9827246 - Biomarkers of response to NAE inhibitors (2017-11-28),

14. 9796683 - Tetrasubstituted alkene compounds and their use (2017-10-24),

15. 9481669 - Pladienolide pyridine compounds and methods of use (2016-11-01),

Title: The Inventor Profile of Peter G Smith

Introduction: Peter G Smith is a renowned inventor based in Arlington, Massachusetts, known for his groundbreaking contributions to various industries.

Latest Patents: Peter G Smith holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Peter G Smith has established himself as a leading figure in the world of inventions, with numerous successful products launched under his name.

Collaborations: Throughout his career, Peter G Smith has collaborated with top companies, research institutions, and universities to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Peter G Smith's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and beyond.